Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone plus misoprostol versus misoprostol alone for early pregnancy failure
NL-OMON22735Active, not recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of mifepristone, misoprostol and Placebo-COD Research Private Ltd in Pregnancy loss and missed abortion (2 arms), sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: Complete evacuation / successful treatment. Started Jun 2018; status: active, not recruiting.
02
Drugs
mifepristonemisoprostolPlacebo-COD Research Private Ltd
03
Conditions
Pregnancy lossmissed abortion
Beyond the preview
Go deeper on NL-OMON22735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22735.